About TEVA-TEMOZOLOMIDE

TEVA-TEMOZOLOMIDE is a prescription medication containing the active ingredient temozolomide, used in the treatment of certain types of brain cancer, including glioblastoma multiforme (GBM) and anaplastic astrocytoma (AA). It is an alkylating agent that works by interfering with the DNA replication process in cancer cells, ultimately leading to cell death.

Key Benefits & Uses

Treatment of glioblastoma multiforme (GBM) in adults
Treatment of anaplastic astrocytoma (AA) in adults
Adjuvant treatment of high-grade glioma in adults

Active Ingredient & Action

Temozolomide is a chemotherapeutic agent that belongs to the class of alkylating agents. It works by adding an alkyl group to the DNA of cancer cells, which interferes with their ability to replicate and ultimately leads to cell death. This mechanism of action allows temozolomide to selectively target and kill cancer cells while minimizing harm to healthy cells.

Important Notes

TEVA-TEMOZOLOMIDE is available in capsule form and should be taken orally. The dosage and administration schedule should be strictly followed as prescribed by a healthcare professional. Patients should be aware of the potential side effects, including nausea, vomiting, fatigue, and bone marrow suppression. Regular monitoring of blood counts and liver function is recommended during treatment. It is essential to inform your doctor of any medical history, including previous chemotherapy or radiation therapy, before starting treatment with TEVA-TEMOZOLOMIDE.